| |
| |
|
| Insider
Information: |
Mahoney Michael F |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,685,562 |
|
|
Indirect Shares
|
196,852 |
|
|
| Direct
Value |
$113,223,691 |
|
|
|
Indirect Value
|
$12,686,293 |
|
|
| Total
Shares |
1,882,414 |
|
|
| Total
Value |
$125,909,984 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
Chairman, President & ... |
2024-02-18 |
1,673,878 |
2024-02-18 |
176,245 |
Premium* |
|
|
Baxter International Inc |
BAX |
Director |
2023-05-02 |
9,692 |
2023-05-02 |
20,397 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
Director |
2023-11-15 |
1,992 |
2023-11-15 |
210 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,307 |
1,681,111 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-18 |
4 |
D |
$65.82 |
$476,076 |
D/D |
(7,233) |
1,673,878 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-17 |
4 |
D |
$65.82 |
$535,182 |
D/D |
(8,131) |
1,664,804 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,333 |
1,672,935 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,265 |
1,661,816 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-16 |
4 |
D |
$65.82 |
$474,825 |
D/D |
(7,214) |
1,654,602 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,523 |
1,652,879 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-14 |
4 |
D |
$65.95 |
$483,282 |
D/D |
(7,328) |
1,645,551 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(65,047) |
1,636,356 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
146,666 |
1,701,403 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-01-01 |
4 |
D |
$57.81 |
$2,318,412 |
D/D |
(40,104) |
1,554,737 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
95,919 |
1,594,841 |
0 |
- |
|
| CVS |
CVS/Caremark Corp |
Director |
• • – |
2023-11-15 |
4 |
A |
$69.13 |
$125,609 |
D/D |
1,817 |
1,817 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-11-06 |
4 |
OE |
$13.08 |
$1,662,527 |
D/D |
113,356 |
1,612,278 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-11-06 |
4 |
AS |
$52.51 |
$5,951,983 |
D/D |
(113,356) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-10-09 |
4 |
AS |
$52.09 |
$5,904,481 |
D/D |
(113,355) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-10-09 |
4 |
OE |
$13.08 |
$1,662,514 |
D/D |
113,355 |
1,612,277 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-09-12 |
4 |
AS |
$53.91 |
$6,110,447 |
D/D |
(113,355) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-09-12 |
4 |
OE |
$13.08 |
$1,662,514 |
D/D |
113,355 |
1,612,277 |
0 |
- |
|
| BAX |
Baxter International Inc |
Director |
– • – |
2023-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,573 |
9,692 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,825 |
1,858,302 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-21 |
4 |
D |
$46.23 |
$344,968 |
D/D |
(7,462) |
1,850,840 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-18 |
4 |
D |
$46.54 |
$336,624 |
D/D |
(7,233) |
1,841,477 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,307 |
1,848,710 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-02-17 |
4 |
D |
$46.54 |
$378,417 |
D/D |
(8,131) |
1,832,403 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
